Just four years, this traded at $2, and over $8 last April. It's had 3 CEOs in 18 months, but it was a viable cancer franchise that could be a huge business in a couple years. Gilead announced it was buying it today for $88. Immunomedics shot up nearly 98%.
Immonumedics is a American stock, trading under the symbol IMMU-Q on the NASDAQ (IMMU). It is usually referred to as NASDAQ:IMMU or IMMU-Q
In the last year, there was no coverage of Immonumedics published on Stockchase.
Immonumedics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Immonumedics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Immonumedics. The stock is worth watching.
On 2020-10-21, Immonumedics (IMMU-Q) stock closed at a price of $87.8.